🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Establishing New Treatment Approaches for Amblyopia: Perceptual Learning and Video Games

RecruitingNAAges any - anyAllNova Southeastern University
NCT05522972 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Amblyopia, a developmental abnormality that impairs spatial vision, is a major cause of vision loss, resulting in reduced visual acuity and reduced sensitivity to contrast. This study uses psychophysical measures to study neural plasticity in both adults and children with amblyopia.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * adults and children with normal vision or amblyopia * amblyopia: interocular VA difference of 0.1 logMAR or more Exclusion Criteria: * any ocular pathological conditions, nystagmus
💊

What it tests

  • Video Game Vision Training
  • Perceptual Learning
  • Occlusion Therapy
📍

Where

1 site
Nova Southeastern University College of Optometry
Fort Lauderdale, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy